Many people view precision medicine as healthcare’s next frontier. The field promises a future where treatments are tailored to each patient’s unique genes, biology and disease risk, with the goal of ...

Three health systems are suing CVS Health, alleging the company and its pharmacy subsidiaries diverted roughly $250 million in savings from the 340B Drug Pricing Program. The 340B program was ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Most disputes between pharmaceutical companies and generic drugmakers end in settlements. Five years of class-action litigation over a Takeda Pharmaceutical gastrointestinal drug culminated this week ...

To combat rising healthcare costs, employers may be looking to reduce healthcare benefits in 2026, according to a new survey from consulting firm Mercer. The survey, released Wednesday, revealed that ...

Employer advocates said Cost Plus Wellness could help spur more direct contracting and transparency in healthcare, though ...

A few months ago a clinic executive pulled me aside at a conference. The executive knew some of the clinics we partnered with and said: “We tried an AI Voice Agent. It didn’t bring the results we ...

On Thursday, Microsoft joined the running list of tech companies that have rolled out a healthcare-focused chatbot this year. The tech giant is rolling out Copilot Health — a new feature in its ...

Accountable care organizations (ACOs) in the Medicare Shared Savings Program saved $2.4 billion in 2024, according to data released last week by the Centers for Medicare and Medicaid Services (CMS).

In a recent letter, a group of 48 employer and consumer organizations are calling on the Trump Administration to strengthen oversight of certified independent dispute resolution (IDR) entities, which ...

Next-generation obesity drugs are testing combination approaches intended to lead to greater weight reduction and one of them, an experimental Eli Lilly medication that hits three targets, now has ...